WO2010079914A3 - A composition comprising the compound isolated from the extract of rubiae radix for preventing and treating inflammatory diseases - Google Patents

A composition comprising the compound isolated from the extract of rubiae radix for preventing and treating inflammatory diseases Download PDF

Info

Publication number
WO2010079914A3
WO2010079914A3 PCT/KR2009/007837 KR2009007837W WO2010079914A3 WO 2010079914 A3 WO2010079914 A3 WO 2010079914A3 KR 2009007837 W KR2009007837 W KR 2009007837W WO 2010079914 A3 WO2010079914 A3 WO 2010079914A3
Authority
WO
WIPO (PCT)
Prior art keywords
preventing
inflammatory diseases
extract
composition
treating inflammatory
Prior art date
Application number
PCT/KR2009/007837
Other languages
French (fr)
Other versions
WO2010079914A2 (en
Inventor
Young Ho Kim
Do Youn Jun
Hyun Ju Woo
Mi Hee Woo
Chae Ha Yang
Original Assignee
Industry-Academic Coorperation Foundation Daegu Haany University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industry-Academic Coorperation Foundation Daegu Haany University filed Critical Industry-Academic Coorperation Foundation Daegu Haany University
Publication of WO2010079914A2 publication Critical patent/WO2010079914A2/en
Publication of WO2010079914A3 publication Critical patent/WO2010079914A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

The present invention is related to the inventive compositions comprising the compounds isolated from Rubiae radix showing potent anti-inflammatory effect through various experiments, therefore, it can be used as the effective and safe therapeutics or health food for treating and preventing inflammatory diseases.
PCT/KR2009/007837 2009-01-06 2009-12-28 A composition comprising the compound isolated from the extract of rubiae radix for preventing and treating inflammatory diseases WO2010079914A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090000936A KR101072663B1 (en) 2009-01-06 2009-01-06 A composition comprising the compound isolated from the extract of Rubiae Radix for preventing and treating inflammatory disease
KR10-2009-0000936 2009-01-06

Publications (2)

Publication Number Publication Date
WO2010079914A2 WO2010079914A2 (en) 2010-07-15
WO2010079914A3 true WO2010079914A3 (en) 2010-10-07

Family

ID=42316951

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/007837 WO2010079914A2 (en) 2009-01-06 2009-12-28 A composition comprising the compound isolated from the extract of rubiae radix for preventing and treating inflammatory diseases

Country Status (2)

Country Link
KR (1) KR101072663B1 (en)
WO (1) WO2010079914A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101103426B1 (en) * 2009-04-10 2012-01-09 영남대학교 산학협력단 Pharmaceutical composition for treating inflammatory bowel disease comprising mollugin or its analogues
CN102875517A (en) * 2012-10-08 2013-01-16 河南大学 Mollugin and preparation method and application thereof
CN102920814B (en) * 2012-11-21 2014-02-26 孙振玲 Traditional Chinese medicine for treating chronic rheumatism
KR20160137042A (en) * 2015-05-22 2016-11-30 주식회사 더삼점영 A composition of plant extract for treating acne patients
KR102149057B1 (en) 2015-06-02 2020-08-27 경북대학교 산학협력단 Apoptosis inhibitor comprising 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone and use thereof
KR102496013B1 (en) * 2015-11-30 2023-02-06 (주)아모레퍼시픽 Skin external composition containing aralosides
KR102445386B1 (en) 2020-08-27 2022-09-20 경희대학교 산학협력단 A composition for prevention or treatment of bone disease comprising anthraquinone
CN113679704B (en) * 2021-10-13 2023-08-25 张惊宇 Application of compound in preparation of medicine for relieving neuropathic pain

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61268648A (en) * 1985-05-22 1986-11-28 Rooto Seiyaku Kk Production of oleanolic acid
KR20030042123A (en) * 2001-11-21 2003-05-28 한국생명공학연구원 Triterpenoid compounds with apoptosis-inducing activity on cells
KR20030055678A (en) * 2001-12-27 2003-07-04 류종훈 Composition containing an extract of rubiae radix for protecting brain cells and treating brain stroke
US20060239957A1 (en) * 2001-10-03 2006-10-26 Sederma Sas Cosmetic and dermopharmaceutical compositions for skin prone to acne

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61268648A (en) * 1985-05-22 1986-11-28 Rooto Seiyaku Kk Production of oleanolic acid
US20060239957A1 (en) * 2001-10-03 2006-10-26 Sederma Sas Cosmetic and dermopharmaceutical compositions for skin prone to acne
KR20030042123A (en) * 2001-11-21 2003-05-28 한국생명공학연구원 Triterpenoid compounds with apoptosis-inducing activity on cells
KR20030055678A (en) * 2001-12-27 2003-07-04 류종훈 Composition containing an extract of rubiae radix for protecting brain cells and treating brain stroke

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SON, JONG KEUN ET AL.: "Anticancer Constituents from the Roots of Rubia cord- ifolia L.", CHEM. PHARM. BULL., vol. 56, no. 2, February 2008 (2008-02-01), pages 213 - 216 *

Also Published As

Publication number Publication date
KR101072663B1 (en) 2011-10-11
WO2010079914A2 (en) 2010-07-15
KR20100081627A (en) 2010-07-15

Similar Documents

Publication Publication Date Title
WO2010079914A3 (en) A composition comprising the compound isolated from the extract of rubiae radix for preventing and treating inflammatory diseases
WO2007117394A3 (en) Compositions and methods related to fructosamine-3-kinase inhibitors
WO2010083307A3 (en) Synergistic fungicidal compositions including hydrazone derivatives and copper
WO2012083112A3 (en) C- 17 -heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
WO2008061724A3 (en) Compositions comprising carnosic acid 12-methylether
WO2010033977A3 (en) Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
WO2014028600A3 (en) 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
WO2011149301A3 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
WO2011025286A3 (en) Lipoteichoic acid-derived glycolipids, and compositions comprising same
WO2009097113A3 (en) Oxazole and thiazole compounds as b-catenin modulators and uses thereof
TN2015000362A1 (en) Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (akr1 c3)
WO2008149353A3 (en) Telomerase activating compounds and methods of use thereof
WO2009025532A3 (en) Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same
ZA201101517B (en) Compositions for the prophylaxis and treatment of dermatological/mucosal diseases,and uses thereof
EP2040726A4 (en) Trachelospermi caulis extract composition for the treatment and prevention of inflammatory diseases
WO2011041680A3 (en) Compositions and methods of prophylaxis for contact dermatitis
WO2010027458A3 (en) Pdk inhibitor compounds and methods of use thereof
WO2008098143A3 (en) Antimicrobial compounds and methods of use
MX2018007724A (en) Pharmaceutical composition for the treatment of prostatic hyperplasia.
WO2014108336A8 (en) Pyrazolyl-based carboxamides ii as crac channel inhibitors
WO2014108337A8 (en) Pyrazolyl-based carboxamides i as crac channel inhibitors
WO2013006526A3 (en) Tricyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
WO2009104913A3 (en) Composition comprising an extract of mixed herbs with lonicera japonica thunb and anemarrhena asphodeloides bunge for preventing and treating arthritic diseases
WO2009104900A3 (en) Composition comprising a flower extract of lonicera japonica thunb for preventing and treating arthritic diseases
WO2013071400A8 (en) Apocynin-lipoic acid conjugates and uses thereof cross-reference to related applications

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09837674

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09837674

Country of ref document: EP

Kind code of ref document: A2